In the 28th May 2009 release the following Content sources have been updated:

• FDA Classic Collection:
  • 757 New Drugs (list upon request)
  • 5,771 New FDA Approval Documents
  • 126,582 New pages of FDA Approval documents
• FDA Approval Packages (not included in FDA Classic Collection)
  • 8 New Drugs
    • Adapalene; Benzoyl Peroxide
    • Choline Fenofibrate
    • Dexlansoprazole
    • Febuxostat
    • Fospropofol Dipodies
    • Gadofosveset Trisodium
    • Milnacipran Hydrochloride
    • Plerixafor
  • 670 New FDA Approval Documents
  • 19,295 New pages of FDA Approval Documents
• EMA (Europe) EPAR document database:
  • 19 New Drugs
    • Brinzolamide; Timolol
    • Clopidogrel; Acetylsalicylic Acid
    • Contusugene Ladenovec
    • Dabigatran Etexilate
    • Dalbavancin
    • Glucarpidase
    • Histamine Dihydrochloride
    • Icatibant
    • Lasofoxifene
    • Nicotinic Acid; Laropiprant
    • Nimotuzumab
    • Prasugrel
    • Recombinant Human C1 Inhibitor
    • Rivaroxaban
    • Satavaptan
    • Sugammadex
    • Telavancin
    • Tocilizumab
    • Ustekinumab
  • 673 New documents
  • 8,662 New pages of EPAR documents
• Extracted Safety data observations :
  • 140,000 new extracted data lines (FDA, FDA Classic & EMA)
• New Totals:
  • 1,252,603 pages of FDA Approval documents (FDA & FDA Classic Collection)
  • 52,476 FDA Approval documents
  • 4,003 Drugs with data in PharmaPendium
  • 817,000 extracted data lines in the Safety database
  • 2,000,000 AERS (post-marketing) reports.